U.S. Weighs Not Paying For All Uses Of Some Drugs
Article Abstract:
Medicare is considering denial of coverage of four unapproved cancer drugs. This could have further consequences for other drugs that elderly cancer patients use but are expensive and not approved by the FDA. The four drugs include Bexxar, Zevalin, Camptosar, and Eloxatin.
Publisher: The New York Times Company
Publication Name: The New York Times
Subject: News, opinion and commentary
ISSN: 0362-4331
Year: 2004
Government expenditures, Government domestic functions, Financial management, Finance, Economic policy, Drug therapy, Cancer, Insurance, United States. Food and Drug Administration, Medicare, Company financing, Health policy
Publication Name: The New York Times
Subject: News, opinion and commentary
ISSN: 0362-4331
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
Over the Counter, Yes, but Out of the Insurance Plan
Article Abstract:
As many prescription drugs become available over the counter and are no longer covered by most drug plans, those with health insurance must shop carefully for the best rates.
Publisher: The New York Times Company
Publication Name: The New York Times
Subject: News, opinion and commentary
ISSN: 0362-4331
Year: 2004
Sales & consumption, Commodity & service prices, Accident & Health Insurance, Insurance Carriers, Direct Health and Medical Insurance Carriers, Hospital and medical service plans, Medical Care Insurance, Drugs Reimbursement Benefits, Prices and rates, Health insurance, Prescription drug plans, Nonprescription drugs, Company pricing policy, Industry sales and revenue
Publication Name: The New York Times
Subject: News, opinion and commentary
ISSN: 0362-4331
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
Subjects list: United States, Drugs
Similar abstracts:
- Abstracts: U.S. trademark court rules against Molson claim as oldest brewer. Merck to axe 7,000 jobs, 235 in Canada
- Abstracts: U.S. Insurer Of Pensions Says Its Deficit Has Soared. U.S. Cancels Pension Plan At Kaiser. Pension Gap Is Closing, G.M. Reports
- Abstracts: Stormy times ahead for the markets. Going for broke. Performance anxiety
- Abstracts: Up against the wall. Seeing red
- Abstracts: Heavier workload, demand boost directors' pay by 30%. Why it pays to be in the boardroom
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.